MYH16
Putative uncharacterized protein MYH16
Also known as: MYH16_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for MYH16 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
1097 residues, UniProt reviewed canonical sequence.
>Q9H6N6|MYH16
1 MGLKVIQQNV HKFLQLRFWG WWKLYNKVKP LLNVARQEEE MKAKEEELRK AMAQTQELVN
61 KVKELEEKTA TLSQEKNDLT IQLQAEQENL MDAEERLTWM MKTKMDLESQ ISDMRERLEE
121 EEGMAASLSA AKRKLEGELS DLKRDLEGLE TTLAKTEKEK QALDHKVRTL TGDLSLREDS
181 ITKLQKEKRA LEELHQKTLD DLQAEEDKVN HLTKNNSKLS TQIHELEDNW EQEKKIRAEV
241 EKARRKAESD LKMTIDNLNE MERSKLDLEE VVKKRDLEIN SVNSKYEDEQ SLNSTLQRKL
301 KEHQDRIEEL EEELEAERAM RAKIEQNRKR EAELLKLRRE LEEAALQSEA TASTLRKKHV
361 DSMAELTEHV ESLQRVKSKL EKDKQVMKAE IDDLNASMET IQKSKMNAEA HVRKLEDSLS
421 EANAKVAELE RNQAEINAIR TRLQAENSEL SREYEESQSR LNQILRIKTS LTSQVDDYKR
481 QLDEESKSRS TAVVSLANTK HDLDLVKEQL EEEQGGKSEL QRLVSKLNTE VTTWRTKYET
541 DAIQRTEELE ETKRKLAARL QEAEEAAETA QARAASLEKN KQRLQAEVED LTIDLEKANA
601 AAAALDKKQR LFDKMLAEWQ QKCEELQVEV DSSQKECRMY MTESFKIKTA YEESLEHLES
661 VKKENKTLQE EIKDLIDQLG EGGRSVHELQ KLKKKLEMEK EELQVALEEA ESSLEVEESK
721 VIRIQLELAQ VKADIDRRIH EKEEEFEATR KNHQRAIESL QASLEAEAKG RAEALRLKKK
781 METDLNEMEI QLDHANKNNS ELVKTLKRLQ QQIKDLQVQM DEDARQHEEL RKQYNLQERR
841 LSLLQTELEE VRSALEGSER SRKLLEQEVV EITEWHNEIN IQNQSLLVVK RKLESDVQRI
901 SNEHEELISE FRLTEERAKK AMMDAARMAE ELRQEQDHCM HLEKIKKNYE VTIKDLQAKM
961 EEAEQLALKG GKRTIMKLEA RIKELETELD GEQKQHVETV KTLCKNERRL KELVFQTEED
1021 HKTNQRMQAL VEKLQNKLKV YKRQIEEAED QANQTLARYR KTVHELDDAE DRAGMAETAL
1081 NKLRTRHRVA GKGITSVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYH16 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 1% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYH16 as an antibody target. Whether an autoantibody or antibody against MYH16 could matter depends on whether native MYH16 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYH16 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MYH16 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...